Depressive Disorders - Belgium | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$140.40m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.46%, resulting in a market volume of US$143.60m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$249.90 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Belgium is experiencing significant growth and development.

Customer preferences: Customers in Belgium are increasingly seeking treatment for depressive disorders due to a growing awareness of mental health issues and the availability of effective treatment options. The stigma surrounding mental health is gradually decreasing, leading more individuals to seek help for their depressive symptoms. Additionally, the aging population in Belgium is contributing to the rising demand for treatment, as older adults are more susceptible to depressive disorders.

Trends in the market: One major trend in the Depressive Disorders market in Belgium is the increasing use of pharmacological interventions. Antidepressant medications are widely prescribed in Belgium, and the market for these drugs is expanding. The availability of new and improved antidepressant medications, along with the growing acceptance of medication-based treatment, is driving the growth in this segment.Another trend in the market is the rising popularity of psychotherapy as a treatment option. Cognitive-behavioral therapy (CBT) and other forms of talk therapy are becoming more widely accepted and sought after by patients. Psychotherapy offers a non-pharmacological alternative for those who prefer not to take medication or who have not found medication to be effective.

Local special circumstances: Belgium has a well-developed healthcare system that provides accessible and affordable mental health services to its population. The government has implemented policies to improve access to mental health care, including the reimbursement of psychotherapy sessions. This has made treatment more affordable and has contributed to the increasing demand for mental health services, including those for depressive disorders.

Underlying macroeconomic factors: The growing Depressive Disorders market in Belgium can be attributed, in part, to the country's strong economy. Belgium has a high GDP per capita and a low unemployment rate, which means that individuals have the financial means to seek treatment for their mental health issues. Additionally, the government's commitment to mental health care and the availability of healthcare coverage for mental health services have also contributed to the growth of the market.In conclusion, the Depressive Disorders market in Belgium is experiencing significant growth and development. Customers are increasingly seeking treatment for depressive disorders, and there is a growing acceptance of both pharmacological and non-pharmacological interventions. Belgium's well-developed healthcare system, government policies, and strong economy have all contributed to the growth of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.